TrialAlcohol and alcoholism (Oxford, Oxfordshire)

Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies.

Wim van den Brink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.